ClinicalTrials.govpublic full text
Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women
postmenopausal symptoms, menopause, hot flashes, vasomotor symptoms, climacteric symptoms, perimenopause, mesafem, brisdelle, low-dose mesylate salt of paroxetine (ldmp), interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 855593
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.